Literature DB >> 18702998

The ancestry of LRRK2 Gly2019Ser parkinsonism.

Hani T S Benamer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702998     DOI: 10.1016/S1474-4422(08)70178-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  Receptor-interacting protein (RIP) kinase family.

Authors:  Duanwu Zhang; Juan Lin; Jiahuai Han
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

2.  Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.

Authors:  Anat Bar-Shira; Carolyn M Hutter; Nir Giladi; Cyrus P Zabetian; Avi Orr-Urtreger
Journal:  Neurogenetics       Date:  2009-03-13       Impact factor: 2.660

3.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.